The course is devoted to providing PhD students engaged in the early drug discovery process with the concepts, the strategies and the methodologies that assist the identification of high-quality drug candidates. This is of utmost importance, as of the thousands of novel compounds that a drug discovery project leads to, only a fraction of these have sufficient ADMET properties to become a clinical candidate.